The ionophore monensin inhibits mouse polyomavirus DNA replication and destabilizes viral early mRNAs

A Iacoangeli1, G Melucci-Vigo, G Risuleo

  • 1Dipartimento di Genetica e Biologia Molecolare, Università La Sapienza, Rome, Italy.

Biochimie
|March 16, 2000
PubMed

Insights

Monensin, an ionophore, inhibits viral DNA replication by reducing viral early messenger RNA stability. This leads to decreased viral early antigens and halts viral DNA synthesis in mouse polyomavirus.

Area of Science:

  • Biochemistry
  • Virology
  • Cell Biology

Background:

  • Monensin is an ionophore compound with diverse biological activities.
  • It affects intracellular pH, membrane transport, and protein secretion.
  • Monensin is known to inhibit the proliferation of various RNA and DNA viruses.

Purpose of the Study:

  • To investigate the effect of monensin on viral DNA replication.
  • To determine the impact of monensin on viral early messenger RNA (mRNA) stability.
  • To elucidate the mechanism by which monensin inhibits mouse polyomavirus DNA synthesis.

Main Methods:

  • Treatment of mouse polyomavirus-infected cells with monensin.
  • Analysis of viral DNA replication.
  • Measurement of viral early mRNA half-life using quantitative techniques.

Main Results:

  • Monensin effectively abolished viral DNA replication of mouse polyomavirus.
  • The half-life of viral early mRNAs was significantly reduced in the presence of monensin.
  • A reduced intranuclear pool of viral early antigens was observed.

Conclusions:

  • Monensin inhibits mouse polyomavirus DNA synthesis.
  • The reduction in viral DNA synthesis is attributed to decreased viral early mRNA stability.
  • This leads to a diminished pool of viral early antigens, ultimately halting viral DNA replication.

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
In-vitro Mutagenesis (Gene Knockouts)02:29

In-vitro Mutagenesis (Gene Knockouts)

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.